Restore Myocardial Function With CorMatrix® ECM® Particulate (P-ECM)

计划入组 9 人 · 首次发布于 2014 年 5 月 15 日

CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM

计划入组 44 人 · 首次发布于 2012 年 2 月 20 日

CorMatrix Cor TRICUSPID ECM Valve Replacement Study

计划入组 78 人 · 首次发布于 2015 年 3 月 25 日

E. coli K1 E11 ∆aroA vaccine

TYF-ARSA

ETV ARSA

Aroa Biosurgery Ltd

Canada

AROA BIOSURGERY LIMITED

New Zealand

Aros Pharma ApS

Denmark

Endoform Natural Demonstrates Significant Healing Advantage for Venous Leg Ulcers in Large Real-World Study

FDA Approves IDE for ECM Therapeutics' Novel Hydrogel Treatment for Anorectal Fistulas

Engitix Secures €21 Million Series A Extension to Advance ECM-Targeted Cancer and Fibrosis Therapies